Atomera Provides First Quarter 2026 Results
Rhea-AI Summary
Atomera (NASDAQ:ATOM) reported Q1 2026 results and a corporate update on May 5, 2026. Key items: $25.0M registered direct offering closed, $41.1M in cash and short-term investments as of March 31, 2026, net loss of $6.1M (−$0.17 per share), and adjusted EBITDA loss of $4.9M. The company said MST moved into customer evaluation for Gate-All-Around transistors and expanded GaN offerings into RF applications. A live webinar was scheduled for May 5, 2026, at 2:00 p.m. PT.
Positive
- $25.0M registered direct offering closed raising liquidity
- Cash, cash equivalents and short-term investments increased to $41.1M as of Mar. 31, 2026
- MST entered customer evaluation phase with a Gate-All-Around manufacturer
Negative
- Net loss widened to $6.1M in Q1 2026 from $5.2M in Q1 2025 (≈17% increase)
- Adjusted EBITDA loss increased to $4.9M in Q1 2026 from $4.4M in Q1 2025
Market Reaction – ATOM
Following this news, ATOM has declined 35.89%, reflecting a significant negative market reaction. Our momentum scanner has triggered 92 alerts so far, indicating high trading interest and price volatility. The stock is currently trading at $6.77. This price movement has removed approximately $229M from the company's valuation.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Market Reality Check
Peers on Argus
ATOM was down 6.49% ahead of results. Momentum data show peers mixed, with DQ and SMTK down and AXTI up, while other close peers like INTT (-3.13%) and ASYS (-5.29%) were also weaker. This points to both company-specific earnings and broader semiconductor materials volatility.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 28 | Q3 2025 earnings | Negative | -2.5% | Record MST wafers but widening losses and lower cash balance. |
| Aug 05 | Q2 2025 earnings | Negative | -22.9% | Larger net loss and declining cash despite new collaborations. |
| May 06 | Q1 2025 earnings | Positive | +18.5% | Strategic agreements and GaN progress alongside recurring losses. |
| Feb 11 | Q4/FY 2024 earnings | Negative | -38.5% | Revenue down year over year with continued net losses. |
| Oct 29 | Q3 2024 earnings | Positive | +28.2% | Narrower loss and new GaN collaboration despite lower cash. |
Earnings releases have often triggered sizable moves, with the average one-day reaction of -3.41% and all observed moves directionally matching the tone of the news.
Over the past few quarters, Atomera’s earnings updates have highlighted ongoing net losses alongside progress in MST commercialization and partnerships. Prior reports showed cash balances in the $17.3M–$26.8M range and net quarterly losses near $4.6M–$5.6M with share count steadily rising from 28.3M to 31.5M. Price reactions swung sharply both up and down, but always aligned with perceived news tone. Today’s Q1 2026 results fit this pattern of operating losses paired with strategic updates on MST adoption and GaN/RF expansion.
Historical Comparison
In the past five earnings releases, ATOM’s average one-day move was -3.41%, with reactions consistently matching the news tone. Today’s -6.49% pre-release decline sits somewhat below that average but within the historically broad earnings-driven volatility range.
Earnings updates have chronicled recurring net losses but growing MST engagement, rising share count, and a strengthening cash position, framing today’s larger cash balance and continued loss as part of an extended commercialization phase.
Market Pulse Summary
This announcement combines Q1 2026 financials with updates on MST adoption in gate-all-around structures and expanded GaN offerings in RF. The company reported a larger net loss and adjusted EBITDA loss year over year but also significantly increased cash to over $41 million, helped by a $25 million equity raise. Historically, earnings have brought sizable price swings, underscoring the importance of tracking cash usage, engagement with major manufacturers, and any shift toward commercial revenue in upcoming quarters.
Key Terms
registered direct offering financial
gate-all-around technical
rf technical
adjusted ebitda financial
non-gaap financial
AI-generated analysis. Not financial advice.
LOS GATOS, CA / ACCESS Newswire / May 5, 2026 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2026.
Recent Company Highlights
Completed
$25 Million registered direct offering of common stockMST in Gate-All-Around structures has moved into the evaluation phase for customers
Expanded GaN offerings to RF applications demonstrating breakthrough improvements to enhance RF performance
Management Commentary
"We made excellent progress during the first quarter toward adoption of MST by GAA manufacturers, engaging with another of the four companies that manufacture those advanced transistors. At the same time, we expanded our offerings in GaN beyond power applications to RF where we believe we will substantially grow our TAM and deliver highly differentiated device performance on larger-diameter wafers," said Scott Bibaud, President and CEO of Atomera. "We are also very pleased to have closed on a
Financial Results
The Company incurred a net loss of (
The Company had
The total number of shares outstanding was 38.7 million as of Mar. 31, 2026.
First Quarter 2026 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, May 5, 2026
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow -
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
March 31, | December 31, | |||||||
2026 | 2025 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 14,160 | $ | 19,210 | ||||
Short-term investments | 26,930 | - | ||||||
Accounts receivable | 41 | - | ||||||
Interest receivable | 139 | 54 | ||||||
Prepaid expenses and other current assets | 788 | 338 | ||||||
Total current assets | 42,058 | 19,602 | ||||||
Property and equipment, net | 51 | 60 | ||||||
Security deposit | 14 | 14 | ||||||
Operating lease right-of-use asset | 1,176 | 884 | ||||||
Financing lease right-of-use-asset | 322 | 533 | ||||||
Total assets | $ | 43,621 | $ | 21,093 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 677 | $ | 608 | ||||
Accrued expenses | 213 | 168 | ||||||
Accrued payroll related expenses | 782 | 650 | ||||||
Current operating lease liability | 301 | 147 | ||||||
Current financing lease liability | 106 | 420 | ||||||
Deferred Revenue | 96 | 7 | ||||||
Total current liabilities | 2,175 | 2,000 | ||||||
Long-term operating lease liability | 896 | 712 | ||||||
Total liabilities | 3,071 | 2,712 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholders' equity: | - | - | ||||||
Preferred stock | ||||||||
Common stock: | 39 | 32 | ||||||
Additional paid in capital | 288,301 | 260,043 | ||||||
Other comprehensive income (loss) | (23 | ) | - | |||||
Accumulated deficit | (247,767 | ) | (241,694 | ) | ||||
Total stockholders' equity | 40,550 | 18,381 | ||||||
Total liabilities and stockholders' equity | $ | 43,621 | $ | 21,093 | ||||
Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2026 | 2025 | 2025 | ||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||
Revenue | $ | 11 | $ | 50 | $ | 4 | ||||||
Cost of revenue | (126 | ) | (131 | ) | - | |||||||
Gross profit (loss) | (115 | ) | (81 | ) | 4 | |||||||
Operating expenses | ||||||||||||
Research and development | 3,457 | 2,740 | 3,255 | |||||||||
General and administrative | 2,333 | 1,505 | 2,088 | |||||||||
Selling and marketing | 419 | 286 | 124 | |||||||||
Total operating expenses | 6,209 | 4,531 | 5,467 | |||||||||
Loss from operations | (6,324 | ) | (4,612 | ) | (5,463 | ) | ||||||
Other income (expense) | ||||||||||||
Interest income | 197 | 195 | 270 | |||||||||
Accretion income | 57 | - | 6 | |||||||||
Interest Expense | (4 | ) | (9 | ) | (21 | ) | ||||||
Other income (expense), net | 1 | 1 | (1 | ) | ||||||||
Total other income (expense), net | 251 | 187 | 254 | |||||||||
Net loss | $ | (6,073 | ) | $ | (4,425 | ) | $ | (5,209 | ) | |||
Net loss per common share, basic and diluted | $ | (0.17 | ) | $ | (0.14 | ) | $ | (0.17 | ) | |||
Weighted average number of common shares outstanding, basic and diluted | 35,256 | 31,590 | 30,243 | |||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
Three Months Ended | ||||||||||||
March 31, | December 31, | March 31, | ||||||||||
2026 | 2025 | 2025 | ||||||||||
Net loss (GAAP) | $ | (6,073 | ) | $ | (4,425 | ) | $ | (5,209 | ) | |||
Depreciation and amortization | 9 | 13 | 12 | |||||||||
Stock-based compensation | 1,406 | 1,334 | 1,009 | |||||||||
Interest income | (197 | ) | (195 | ) | (270 | ) | ||||||
Accretion income | (57 | ) | - | (6 | ) | |||||||
Interest expense | 4 | 9 | 21 | |||||||||
Other (income) expense, net | (1 | ) | (1 | ) | 1 | |||||||
Net loss non-GAAP EBITDA | $ | (4,909 | ) | $ | (3,265 | $ | (4,442 | ) | ||||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
SOURCE: Atomera, Inc.
View the original press release on ACCESS Newswire